Haleon (NYSE:HLN) Shares Gap Up to $6.01

Haleon plc (NYSE:HLNGet Rating) shares gapped up before the market opened on Wednesday . The stock had previously closed at $6.01, but opened at $6.17. Haleon shares last traded at $6.21, with a volume of 58,615 shares changing hands.

Analyst Ratings Changes

Several analysts have recently commented on the company. Morgan Stanley assumed coverage on Haleon in a report on Friday, August 19th. They set an “equal weight” rating for the company. The Goldman Sachs Group assumed coverage on Haleon in a report on Monday, July 25th. They set a “buy” rating for the company. Credit Suisse Group began coverage on Haleon in a report on Monday, July 25th. They set an “outperform” rating for the company. Bank of America began coverage on Haleon in a research note on Monday, July 25th. They issued a “buy” rating for the company. Finally, Citigroup began coverage on Haleon in a research note on Monday, July 25th. They issued a “buy” rating for the company. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and four have given a buy rating to the company. According to MarketBeat, Haleon presently has an average rating of “Hold” and a consensus price target of $250.00.

Haleon Stock Performance

Haleon Company Profile

(Get Rating)

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.

Featured Stories

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.